Genzyme rejects offer from Sanofi again
Health / Medicine Related News
Genzyme has again rejected a hostile $69-a-share offer from Sanofi-Aventis, revealing in a filing that Chris Viehbacher, chief executive of the French pharmaceutical company, proposed entering negotiations based on striking a deal between $69 and $80 a share
Source: FT.com - Pharmaceuticals